250 ORAL OXA-01, a novel potent mTORC1/TORC2 kinase inhibitor, demonstrates broad spectrum antitumor activity in preclinical models of human cancer

✍ Scribed by P.C. Gokhale; S.V. Bhagwat; A.P. Crew; A. Cooke; C. Mantis; J.E. Workman; D. Landfair; M. Bittner; J.A. Pachter; R. Wild

• Book ID: 119599407
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 59 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)72184-0